Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thoralf Lange

Showing results (11-20 of 69) with videos related to

Pageof 7
Sort By:
Therapeutic Drug Monitoring|March 11, 2010
Determination of saliva trough levels for monitoring voriconazole therapy in immunocompromised children and adultsClaudia Michael, Uta Bierbach, Katrin Frenzel, et al.
Gastrointestinal Endoscopy|February 27, 2007
Wireless capsule endoscopy for diagnosis of acute intestinal graft-versus-host diseaseSusanne Neumann, Konrad Schoppmeyer, Thoralf Lange, et al.
Blood|August 27, 2009
Acute dasatinib exposure commits Bcr-Abl-dependent cells to apoptosisJennifer L Snead, Thomas O'Hare, Lauren T Adrian, et al.
Annals of Hematology|July 24, 2015
JAK2V617F molecular remission in a primary myelofibrosis patient treated with ruxolitinibAnne Koehler, Karolin Hubert, Thoralf Lange, et al.
Haematologica|January 10, 2013
JAK2 p.V617F allele burden in myeloproliferative neoplasms one month after allogeneic stem cell transplantation significantly predicts outcome and risk of relapseThoralf Lange, Anja Edelmann, Udo Siebolts, et al.
Haematologica|October 16, 2012
The quantitative level of T315I mutated BCR-ABL predicts for major molecular response to second-line nilotinib or dasatinib treatment in patients with chronic myeloid leukemiaThoralf Lange, Thomas Ernst, Franz X Gruber, et al.
Leukemia & Lymphoma|March 17, 2012
Delayed processing of bone marrow samples reveals a prognostic pattern of NME mRNA expression in cytogenetically normal acute myeloid leukemiaEnrica Bach, Rainer Krahl, Thoralf Lange, et al.
Leukemia & Lymphoma|January 19, 2012
Bcr-Abl dependent post-transcriptional activation of NME2 expression is a specific and common feature of chronic myeloid leukemiaSabine Tschiedel, Enrica Bach, Annette Jilo, et al.
The Journal of Molecular Diagnostics : JMD|November 1, 2019
Comparison of Real-Time Quantitative PCR and Digital Droplet PCR for BCR-ABL1 Monitoring in Patients with Chronic Myeloid LeukemiaGeorg-Nikolaus Franke, Jacqueline Maier, Kathrin Wildenberger, et al.
Critical Reviews in Oncology/Hematology|October 11, 2005
Allogeneic hematopoietic cell transplantation (HCT) following reduced-intensity conditioning in patients with acute leukemiasDietger Niederwieser, Chiara Gentilini, Ute Hegenbart, et al.
Pageof 7

Showing results (11-20 of 69) with videos related to

Sort By:
Pageof 7
Therapeutic Drug Monitoring|March 11, 2010
Determination of saliva trough levels for monitoring voriconazole therapy in immunocompromised children and adultsClaudia Michael, Uta Bierbach, Katrin Frenzel, et al.
Gastrointestinal Endoscopy|February 27, 2007
Wireless capsule endoscopy for diagnosis of acute intestinal graft-versus-host diseaseSusanne Neumann, Konrad Schoppmeyer, Thoralf Lange, et al.
Blood|August 27, 2009
Acute dasatinib exposure commits Bcr-Abl-dependent cells to apoptosisJennifer L Snead, Thomas O'Hare, Lauren T Adrian, et al.
Annals of Hematology|July 24, 2015
JAK2V617F molecular remission in a primary myelofibrosis patient treated with ruxolitinibAnne Koehler, Karolin Hubert, Thoralf Lange, et al.
Haematologica|January 10, 2013
JAK2 p.V617F allele burden in myeloproliferative neoplasms one month after allogeneic stem cell transplantation significantly predicts outcome and risk of relapseThoralf Lange, Anja Edelmann, Udo Siebolts, et al.
Haematologica|October 16, 2012
The quantitative level of T315I mutated BCR-ABL predicts for major molecular response to second-line nilotinib or dasatinib treatment in patients with chronic myeloid leukemiaThoralf Lange, Thomas Ernst, Franz X Gruber, et al.
Leukemia & Lymphoma|March 17, 2012
Delayed processing of bone marrow samples reveals a prognostic pattern of NME mRNA expression in cytogenetically normal acute myeloid leukemiaEnrica Bach, Rainer Krahl, Thoralf Lange, et al.
Leukemia & Lymphoma|January 19, 2012
Bcr-Abl dependent post-transcriptional activation of NME2 expression is a specific and common feature of chronic myeloid leukemiaSabine Tschiedel, Enrica Bach, Annette Jilo, et al.
The Journal of Molecular Diagnostics : JMD|November 1, 2019
Comparison of Real-Time Quantitative PCR and Digital Droplet PCR for BCR-ABL1 Monitoring in Patients with Chronic Myeloid LeukemiaGeorg-Nikolaus Franke, Jacqueline Maier, Kathrin Wildenberger, et al.
Critical Reviews in Oncology/Hematology|October 11, 2005
Allogeneic hematopoietic cell transplantation (HCT) following reduced-intensity conditioning in patients with acute leukemiasDietger Niederwieser, Chiara Gentilini, Ute Hegenbart, et al.
Pageof 7